Bioengineering professor Ali Khademhosseini is one of the world’s leading experts in tissue engineering. Based on support from the National Institutes of Health, he and colleagues at Harvard University and Brigham and Women’s Hospital have developed a novel method to 3D-print blood vessels. The study was published in Advanced Materials.
Khademhosseini is the Levi James Knight, Jr. Chair in Engineering and holds faculty appointments in bioengineering and chemical and biomolecular engineering at UCLA Samueli, and in radiology at the David Geffen School of Medicine. He also is Director of the Center for Minimally Invasive Therapeutics at UCLA.
We asked him about the advantages and challenges of 3D-printing tissues and organs, and how he and his lab benefit by conducting research at UCLA.